FDA approves Bayer/J&J's stroke drug Xarelto

(Reuters) - Drugs regulators on Friday approved the stroke preventer Xarelto from Bayer AG and Johnson & Johnson for people with a common heart rhythm disorder called atrial fibrillation. However, the Food and Drug Administration added a restrictive "black box" warning to the drug, warning people ...

Related News:-

• FDA Panel Gives Nod to Bayer/J&J Anti-Clot Drug


COLLEGE PARK, Md. – A new stroke preventer from Bayer and Johnson & Johnson moved one step closer to U.S. approval, but questions remained about restrictions on ...

• FDA panel gives nod to Bayer/J&J anti-clot drug


A new stroke preventer from Bayer and Johnson & Johnson moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.

• FDA panel gives nod to Bayer/J&J anti-clot drug - Yahoo! News


Read 'FDA panel gives nod to Bayer/J&J anti-clot drug' on Yahoo! News. COLLEGE PARK, Maryland (Reuters) - A new stroke preventer from Bayer and Johnson & Johnson moved one step ...

• Article > Bayer/J&J bloodthinner Xarelto gets OK from FDA


Bayer and Johnson & Johnson are celebrating after regulators in the USA finally gave a thumbs-up to their oral anticoagulant Xarelto. The US Food and Drug Administration has ...

• Bayer/J&J stroke drug not ready for approval-US FDA


WASHINGTON (Reuters) - U.S. drug regulators said an experimental stroke preventer from Bayer (XETRA:BAYGN.DE - News) and Johnson & Johnson (NYSE:JNJ - News) is not ready for ...

• Bayer/J&J stroke drug not ready for approval-US FDA


WASHINGTON (Reuters) - U.S. drug regulators said an experimental stroke preventer from Bayer (BAYGn.DE) and Johnson & Johnson (JNJ.N) is not ready for approval and ...

• FDA Approves Xarelto® (rivaroxaban tablets) for the Prophylaxis ...


{PharmPro via BioPortfolio} Xarelto® is the only new oral anticoagulant with US approval in this indication

• UPDATE 3-Bayer/J&J stroke drug not ready for approval-US FDA


WASHINGTON, Sept 6 (Reuters) - U.S. drug regulators said an experimental stroke preventer from Bayer (BAYGn.DE) and Johnson & Johnson (JNJ.N) is not ready for ...

• FDA Reviewer Recommends `Complete Response` For Bayer, J&J's Xarelto


(Updates with Bayer share price in third paragraph and background in the last paragraph.) WASHINGTON -(Dow Jones)- Food and Drug Administration staff recommended against an ...